Starting the New Working Year
As the new working year begins, Nanjing Junzhuo has officially resumed operations and is moving into 2025 with renewed momentum. Since its founding, the company has remained focused on advanced biomaterials research and development, with hydroxyapatite microspheres as one of its core product directions.
With strong biocompatibility, controllable degradation, and stable mechanical performance, hydroxyapatite microspheres continue to show broad application potential in both aesthetic medicine and orthopedics.
Application Value of Hydroxyapatite Microspheres
In aesthetic medicine, hydroxyapatite microspheres can support facial contour shaping, deep-tissue support, and collagen regeneration through minimally invasive injection-based solutions. Their combination of natural-looking results, lasting support, and material safety makes them an important direction in regenerative aesthetics.
In orthopedics, the material's similarity to the mineral phase of human bone supports its use in bone-defect repair, bone tissue engineering scaffolds, and bone-cement reinforcement. This gives surgeons and developers a more physiologically aligned material option for repair-oriented applications.
Technical Capability and 2025 Direction
Backed by proprietary biomimetic synthesis and precise microsphere-processing technology, Nanjing Junzhuo continues to improve control over particle size, porosity, and degradation rate. That process capability helps expand the role of hydroxyapatite microspheres in regenerative medicine, biomaterial research, and emerging directions such as 3D-printing bioinks.
In 2025, Nanjing Junzhuo will continue to work with customers and partners on higher-quality biomaterials, practical project support, and long-term innovation.